BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 25 filers reported holding BELLEROPHON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | – | 277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Puissance Capital Management LP | 8,298,755 | $21,410,000 | 14.79% |
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 15,138,486 | $37,186,000 | 2.82% |
| VHCP Management II, LLC | 4,149,378 | $9,671,000 | 2.32% |
| Boxer Capital, LLC | 1,857,143 | $4,791,000 | 0.88% |
| EAM Investors, LLC | 237,975 | $614,000 | 0.11% |
| Telemetry Investments, L.L.C. | 79,421 | $205,000 | 0.08% |
| Virtu Financial LLC | 56,569 | $146,000 | 0.01% |
| Renaissance Technologies | 927,200 | $2,392,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 30,348 | $79,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,000 | $59,000 | 0.00% |